Latanoprost 0.005% Ophthalmic Solution
Sponsors
Alcon Research, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Allergan, Ohio State University, Kasr El Aini Hospital
Conditions
Effect of DrugGlaucomaGlaucoma, Open-AngleOHT - Ocular HypertensionOcular HypertensionOpen Angle GlaucomaOpen-angle GlaucomaPrimary Open Angle Glaucoma
Phase 1
Phase 2
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
CompletedNCT00069706
Start: 2003-07-31End: 2003-10-31Updated: 2012-02-14
Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.
CompletedNCT05513924
Start: 2022-03-15End: 2022-12-01Updated: 2023-07-11
Next Generation Rocklatan
CompletedNCT06441643
Start: 2024-09-04End: 2025-11-14Updated: 2025-11-18
Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension
RecruitingNCT06964191
Start: 2025-05-31End: 2026-11-15Target: 75Updated: 2025-06-13
Phase 3
Phase 4
Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US
CompletedNCT00847483
Start: 2002-01-31End: 2002-08-31Updated: 2021-02-02
Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated
CompletedNCT01243567
Start: 2010-06-01End: 2012-02-14Updated: 2019-04-18
A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension
CompletedNCT01525173
Start: 2012-01-31End: 2012-10-31Updated: 2013-12-04
Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance
CompletedNCT04412096
Start: 2020-11-23End: 2025-05-22Updated: 2026-03-04
Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.
NCT05606796
Start: 2022-12-31End: 2023-09-30Target: 76Updated: 2022-11-07
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
RecruitingNCT06883123
Start: 2025-05-14End: 2026-04-01Target: 70Updated: 2025-05-15
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RecruitingNCT07325240
Start: 2025-11-21End: 2027-10-01Target: 30Updated: 2026-03-23
Rocklatan vs Latanoprost Post-DSLT
Not yet recruitingNCT07465913
Start: 2026-05-06End: 2027-05-06Target: 36Updated: 2026-03-12